1. Home
  2. BSRR vs ALT Comparison

BSRR vs ALT Comparison

Compare BSRR & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

HOLD

Current Price

$38.54

Market Cap

479.7M

Sector

Finance

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.93

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSRR
ALT
Founded
1977
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.7M
421.5M
IPO Year
2001
2005

Fundamental Metrics

Financial Performance
Metric
BSRR
ALT
Price
$38.54
$2.93
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$37.00
$17.67
AVG Volume (30 Days)
53.7K
2.7M
Earning Date
04-27-2026
05-08-2026
Dividend Yield
2.93%
N/A
EPS Growth
10.28
25.37
EPS
0.96
N/A
Revenue
N/A
$41,000.00
Revenue This Year
$11.74
N/A
Revenue Next Year
$3.63
N/A
P/E Ratio
$39.15
N/A
Revenue Growth
N/A
105.00
52 Week Low
$26.49
$2.56
52 Week High
$39.00
$7.73

Technical Indicators

Market Signals
Indicator
BSRR
ALT
Relative Strength Index (RSI) 59.34 45.76
Support Level $36.00 $2.87
Resistance Level N/A $3.13
Average True Range (ATR) 0.78 0.12
MACD -0.07 0.01
Stochastic Oscillator 85.20 47.56

Price Performance

Historical Comparison
BSRR
ALT

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: